Nexien BioPharma Inc (NXEN)

[Renegades17]

I disagree to a certain extent

I suggested to Mark that the company put out a substantive update. There was lots of material in the 10-K that could have benefited from further explanation. The last meaningful update that they provided was in the Spring. Much has happened since then but the PRs have only been for one-off events like the CSE listing and the recruitment of an advisor. Not saying those aren't important, but if they're going to realize an appropriate valuation, ie. one commensurate with the growth potential and market opportunity, they need to discuss more.

This is a growth company that will need additional capital. They need to discuss and sell a vision of where the company will be in the next 5-10 years. They have done very little to paint that vision in PRs.

No one is asking them to fabricate information. Just provide additional color on what's already been provided in the 10-K and other filings.